ASCO 2020

Gilead’s Kite submits FDA approval application for CAR-T in slow-growing lymphomas
MedCity News
Tue, 09/8/20 - 10:40 am
Gilead Sciences
Yescarta
follicular lymphoma
marginal zone lymphoma
ASCO 2020
Kite Pharma
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
BioPharma Dive
Fri, 06/5/20 - 11:02 am
Legend Biotech
IPOs
cancer
cell therapies
ASCO 2020
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
Asco 2020 movers – cell therapy companies dominate the risers
EP Vantage
Thu, 06/4/20 - 10:56 am
ASCO 2020
cell therapy
Adaptimmune
Allogene
Iovance
Adaptimmune’s ASCO data for cell therapy in sarcoma spark optimism about Phase II study potential
MedCity News
Tue, 06/2/20 - 10:20 am
Adaptimmune
ASCO 2020
cell therapy
sarcoma
ADP-A2M4
ASCO data for Amgen’s acute leukemia drug disappoint, but path forward remains, experts say
MedCity News
Mon, 06/1/20 - 11:45 pm
ASCO 2020
Amgen
AMG 330
acute myeloid leukemia
ASCO: Myovant details speedy effects of prostate cancer med relugolix
Fierce Biotech
Mon, 06/1/20 - 10:45 am
Myovant
ASCO 2020
Relugolix
prostate cancer
clinical trials
ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data
Fierce Pharma
Mon, 06/1/20 - 12:00 am
Merck
Eisai
liver cancer
ASCO 2020
Keytrua
Lenvima
clinical trials
ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab?
Fierce Pharma
Sun, 05/31/20 - 11:58 pm
AstraZeneca
ASCO 2020
clinical trials
tremelimumab
liver cancer
Imfinzi
Pfizer's Ibrance misses shot at big new market with early breast cancer failure
Fierce Pharma
Sun, 05/31/20 - 11:55 pm
Pfizer
Ibrance
ASCO 2020
clinical trials
HER2-negative breast cancer
Gilead trumpets data with newly-bought magrolimab in blood cancers
Pharmaforum
Sun, 05/31/20 - 11:53 pm
Gilead Sciences
ASCO 2020
Forty Seven
magrolimab
M&A
MDS
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
Ziopharm Phase I Trial Yields Positive Results for Treatment of rGBM
BioSpace
Sat, 05/30/20 - 07:52 pm
Ziopharm Oncology
rGBM
ASCO 2020
glioblastoma multiforme
clinical trials
Allogene’s ALLO-501 Shows Positive Results in Its Phase I ALPHA Trial
BioSpace
Sat, 05/30/20 - 07:50 pm
Allogene
ASCO 2020
ALLO-501
clinical trials
refractory indolent non-Hodgkins lymphoma
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
Motley Fool
Sat, 05/30/20 - 07:48 pm
AstraZeneca
ASCO 2020
lung cancer
adjuvants
Tagrisso
ASCO 2020 virtual annual meeting – day 1 (live updates)
Pharmaforum
Fri, 05/29/20 - 12:39 pm
ASCO 2020
virtual meetings
oncology
cancer
COVID-19
pandemic
Gilead’s newly bought immunotherapy drug scores at ASCO
MedCity News
Fri, 05/29/20 - 12:30 pm
Gilead Sciences
ASCO 2020
magrolimab
clinical trials
AML
MDS
ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma
Fierce Biotech
Fri, 05/29/20 - 10:57 am
Allogene
ASCO 2020
CAR-T
ALLO-501
ALLO-647
lymphoma
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
BioPharma Dive
Thu, 05/28/20 - 11:12 pm
AstraZeneca
Tagrisso
lung cancer
clinical trials
ASCO 2020
ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients
Fierce Pharma
Thu, 05/28/20 - 11:10 pm
Merck
Keytruda
clinical trials
ASCO 2020
colorectal cancer

Pages